A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus

Authors

Institutions

Publication Details

Journal
Diabetes Therapy
Published
2025-03-04
DOI
https://doi.org/10.1007/s13300-025-01700-3
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus

Daniel S. Hsia, AMY SANGHAVI SHAH, Georgeanna J. Klingensmith, Xuejun Peng et al.
1 citations
Diabetes Therapy
Diabetes Treatment and Management
1.29
article

A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus

Daniel S. Hsia, AMY SANGHAVI SHAH, Georgeanna J. Klingensmith, Xuejun Peng, Richard Czerniak, Yunlong Xie, William V. Tamborlane
article en
1 citations

Abstract

No abstract available for this paper.
Diabetes TherapyVol. 16(5)
Pennington Biomedical Research Center (US), Cincinnati Children's Hospital Medical Center (US), Yale University (US), Takeda (United States) (US), University of Colorado Anschutz Medical Campus (US), University of Cincinnati (US)
Good health and well-being
Openalex Percentile: Top 22%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.